A case of meningitis caused by group B Streptococcus treated with high dose of meropenem

Japanese Journal of Antibiotics

Volumn 64, Issue 4, 2011, Pages 239-246

  Yamagishi, Yuka ^a   Mikamo, Hiroshige ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; C REACTIVE PROTEIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MINOCYCLINE; PENICILLIN G; VANCOMYCIN;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; CEREBROSPINAL FLUID; DRUG MEGADOSE; GLASGOW COMA SCALE; GROUP B STREPTOCOCCAL MENINGITIS; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS AGALACTIAE;

ACETAMIDES; AGED; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HUMANS; MALE; MENINGITIS, BACTERIAL; OXAZOLIDINONES; PULSE THERAPY, DRUG; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; THIENAMYCINS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 80053108125     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. DURAND, M. L.; S. B. CALDERWOOD, D. J. WEBER, et al.: Acute bacterial meningitis in adults, a review of 493 episodes. N. Engl. J. Med. 328: 21-28, 1993
2. THIGPEN, M. C.; C. G. WHITNEY, N. E. MESSONNIER, et al.: Bacterial meningitis in the United States, 1998-2007. N. Engl. J. Med. 364: 2016-2025, 2011
3. TUNKEL, A. R.; B. J. HARTMAN, S. L. KAPLAN, et al.: Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. 39: 1267-1284, 2004
4. GILBERT, D. N.; R. C. MOELLERING Jr., G. M. ELIOPOULOS, et al.: The SANFORD GUIDE to antimicrobial therapy 2011 (41 st edition), 6-9, 2011
5. CHAUDHURI, A.; P. MARTINEZ-MARTIN, P. G. KENNEDY, et al.: FENS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur. J. Neurol. 15: 649-659, 2008
6. EDWARDS, M. S. & C. J. BAKER: Streptococcus agalactiae (Group B Streptococcus). MANDELL, G. L.; J. E. BENNETT, R. DOLIN: Mandell, Douglas, and Benett's Principles and Practice of Infectious Diseases, 7th edition. Elsevier, Philadelphia, 2655-2666, 2010
7. MIKAMO, H.; Y. SATO, Y. HAYASAKI, et al.: Preventive procedures against GBS infection by means of antibody measurement. JARMAN 11: 33-37, 2000
8. HOSHINA, K.; Y. SUZUKI, H. NISHIDA, et al.: Trend of neonatal group B streptococcal infection during the last 15 years. Pediatr. Int. 44: 641-646, 2002
9. DARBAR, A. A. & G. L. GILBERT: Phenotypical and genotypical characteristics of invasive group B Streptococcus isolates in Western Sydney 2000-2005. Pathology 39: 589-593, 2007
10. MATSUBARA, K. & G. YAMAMOTO: Invasive group B streptococcal infections in a tertiary care hospital between 1998 and 2007 in Japan. Int. J. Infect. Dis. 13: 679-684, 2009
11. KIMURA, K.; S. SUZUKI, J. WACHINO, et al.: First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 52: 2890-2897, 2008
12. SAKATA, H.; Y. SATO, M. MONOYAMA, et al.: Results of a multicenter survey of diagnosis and treatment for bacterial meningitis in Japan. J. Infect. Chemother. 16: 396-406, 2010
13. Jpn. J. Antibiotics 45: 809-813, 1992
14. ODIO, C. M.; J. R. PUIF, J. M. FERIS, et al.: Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Pediatr. Infect. Dis. J. 18: 581-590, 1999
15. KLUGMAN, K. P. & R. DAGAN: The meropenem meningitis study group: Randomized comparison of meropenem with cefotaxime for the treatment of bacterial meningitis. Antimicrob. Agents Chemother. 39: 1140-1146, 1995
16. SCHMUTZHARD, E.; K. J. WILLIAMS, G. VUKMIROVITIS, et al.: A randomized comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group. J. Antimicro. Chemother. 36: Supple. A85-A97, 1995
17. MARTIN-CANAL, G.; A. SAAVEDRA, J. M. ASENSI, et al.: Meropenem monotherapy is as effective as and safer than imipenem to treat brain abscess. Internat. J. Antimicro. Agents 35: 301-304, 2010
18. NORRBY, S. R.: Neurotoxicity of carbapenem antibiotics: consequences of their use in bacterial meningitis. J. Antimicro. Chemother. 45: 5-7, 2000
19. LINDEN, P.: Safety profile of meropenem. Anupdated review of over 6000 patients treated with meropenem. Drug Safety 30: 657-668, 2007
20. TSUMURA, R.; K. IKAWA, N. MORIKAWA, et al.: The pharmacokinetics and pharmacodynamics of meropenem in the cerebrospinal fluid of neurosurgical patients. J. Chemother. 20: 615-621, 2008